about
Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.Micro-scale devices for transdermal drug deliverySuperresolution and Fluorescence Dynamics Evidence Reveal That Intact Liposomes Do Not Cross the Human Skin BarrierCurrent aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation.Transfersomes for transdermal drug delivery.Vesicles as tools for the modulation of skin permeability.Undulating tubular liposomes through incorporation of a synthetic skin ceramide into phospholipid bilayers.Toxicity of therapeutic nanoparticles.Cutaneous short-interfering RNA therapy.Liposomal systems as drug delivery vehicles for dermal and transdermal applications.Bicelles: lipid nanostructured platforms with potential dermal applications.Nanocarrier-based topical drug delivery for the treatment of skin diseases.Drug delivery to hair follicles.Magnetically responsive liquid core polyelectrolyte nanocapsules.Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.Advanced lipid systems containing β-carotene: stability under UV-vis radiation and application on porcine skin in vitro.Use of solid-state nanopores for sensing co-translocational deformation of nano-liposomes.Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery.Flexosomes for transdermal delivery of meloxicam: characterization and antiinflammatory activity.Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations.Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.Liposomal hydrogel formulation for transdermal delivery of pirfenidone.Improved Delivery of Caffeic Acid through Liposomal Encapsulation
P2860
Q26778469-FA9F87C9-4656-4046-9220-F0A14BC55934Q27489779-08FB57BB-0E78-4789-8FFE-B77AFC4A7BB6Q28552342-B0845DF3-C430-41FC-B084-E9957C87C83CQ33805053-4BA63200-06C2-4524-B9EE-7820113210E4Q34028836-E418AC82-EE5C-4A04-9623-2B33FC5092F8Q35590730-07F5BF07-FD7D-4F42-9EF5-7F686720851CQ36640317-10C58B5D-29F6-4248-86DB-BA605DB474AFQ36985889-D9960FF9-30EE-4038-B1D6-693F5F8AC912Q37365098-856526A4-2FA4-46A8-A1D9-A6618FE093ADQ37385444-510BD716-40D2-4E57-8CB6-31D46847699DQ37639312-94109952-A617-4BD9-BEB3-BE36F4739212Q37909120-0F3E193B-ADB0-4442-B079-FAFE7E34CB25Q37960435-2D8EF6C2-D5D0-433A-8046-B60E739F1A00Q38007558-84945C37-5F7A-44B4-8DF5-F6593B640A7FQ38093232-0C5BDB0B-EA7B-4B9B-AC85-426279904FCFQ39133006-281BE5EF-D276-4590-865B-8B5EE7F3CCA0Q39899988-841EDED2-057B-45F9-87F2-5DA2A7E9944EQ41604813-87AD8EDB-D9D6-433E-A2D1-078BA10BC955Q42152460-62B96673-6282-4AED-8909-E676CB1D2D7DQ42705797-D412BE3F-0BDB-4B5A-8F61-4B66992C0894Q43253529-4E1F6B59-EB3B-4FD3-A60D-CFF573D6D70FQ46944829-C13DD555-E48D-445F-AF64-0B3935C343ABQ50906935-7A23EE9C-98F0-4CD8-8EA9-2C4C356E02B6Q52601462-69DE3388-9875-411F-8A9B-5CB6258C40C1Q53452813-AE7EB10B-A1F9-48BD-8CD0-9798B5ECED33Q59128994-9811C7D4-DC32-4BF0-93B4-57C50827A09D
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Can drug-bearing liposomes penetrate intact skin?
@ast
Can drug-bearing liposomes penetrate intact skin?
@en
type
label
Can drug-bearing liposomes penetrate intact skin?
@ast
Can drug-bearing liposomes penetrate intact skin?
@en
prefLabel
Can drug-bearing liposomes penetrate intact skin?
@ast
Can drug-bearing liposomes penetrate intact skin?
@en
P2860
P356
P1476
Can drug-bearing liposomes penetrate intact skin?
@en
P2093
Brian W Barry
P2860
P304
P356
10.1211/JPP.58.4.0001
P577
2006-04-01T00:00:00Z